Table 9Conflict of Interest Declaration for McGill University Health Centre Clinician 1

Company Check Appropriate Dollar Range
$0 to 5,000 $5,001 to 10,000 $10,001 to 50,000 In Excess of $50,000
GSK for participation in Advisory Boards and Steering Committee—X——
Institutional Grants received from GSK (RUBY, FIRST and GARNET clinical trials)———X

From: Stakeholder Input

Cover of Dostarlimab (Jemperli)
Dostarlimab (Jemperli): CADTH Reimbursement Review: Therapeutic area: Endometrial cancer [Internet].
Copyright © 2022 Canadian Agency for Drugs and Technologies in Health.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.